D'Onofrio Matthew J 4
4 · Evoke Pharma Inc · Filed Aug 8, 2024
Insider Transaction Report
Form 4
Evoke Pharma IncEVOK
D'Onofrio Matthew J
Exec VP, Chief Bus. Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-08-07+64,840→ 64,840 totalExercise: $5.27Exp: 2034-08-06→ Common Stock (64,840 underlying)
Footnotes (1)
- [F1]50% of the total number of shares subject to the options shall vest on the 18th month anniversary of August 7, 2024 (the "Vesting Commencement Date"), and 1/36th of the other 50% of the total number of shares subject to the options shall vest on each monthly anniversary of the Vesting Commencement Date thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date, so that the options shall be fully vested on the third anniversary of the Vesting Commencement Date.